|
HS Code |
875842 |
| Chemical Name | Pyridine, 2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-, monohydrochloride |
| Cas Number | 52235-83-7 |
| Molecular Formula | C20H25Cl2N3 |
| Molecular Weight | 378.34 |
| Appearance | Solid |
| Solubility | Soluble in water |
| Purity | Typically ≥98% |
| Synonyms | 2-[(4-Chlorobenzyl)[2-(dimethylamino)ethyl]amino]pyridine monohydrochloride |
| Storage Temperature | Store at room temperature |
| Iupac Name | 2-[(4-chlorobenzyl)[2-(dimethylamino)ethyl]amino]pyridine monohydrochloride |
| Hazard Statements | Irritant |
As an accredited Pyridine, 2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-, monohydrochloride (8CI) factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging is a sealed amber glass bottle containing 25 grams of Pyridine, 2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-, monohydrochloride. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL) for Pyridine, 2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-, monohydrochloride: Standard 20′ FCL, typically 10–14MT packed in 25kg drums or bags, safely secured for export shipment. |
| Shipping | Pyridine, 2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-, monohydrochloride (8CI) should be shipped in tightly sealed, chemical-resistant containers, protected from moisture and light. Transport must comply with all relevant hazardous materials regulations, utilize appropriate labeling, and include safety documentation. Store and ship at controlled temperatures to prevent degradation or hazardous conditions. |
| Storage | Store Pyridine, 2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-, monohydrochloride in a tightly closed container, in a cool, dry, well-ventilated area, away from incompatible substances such as strong oxidizers and bases. Protect from moisture and direct sunlight. Label clearly and handle using appropriate chemical safety protocols, including the use of gloves and eye protection to avoid contact. |
| Shelf Life | Shelf life: Store Pyridine, 2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-, monohydrochloride in a cool, dry place; stable for 2–3 years. |
|
Purity 98%: Pyridine, 2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-, monohydrochloride (8CI) with a purity of 98% is used in pharmaceutical intermediate synthesis, where high purity ensures minimal by-product formation. Molecular weight 350.90 g/mol: Pyridine, 2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-, monohydrochloride (8CI) with a molecular weight of 350.90 g/mol is used in structure-based drug design, where precise molecular profiling is required for effective target binding studies. Melting point 185°C: Pyridine, 2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-, monohydrochloride (8CI) featuring a melting point of 185°C is used in high-temperature reaction protocols, where solid-state stability enhances process safety. Stability temperature 120°C: Pyridine, 2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-, monohydrochloride (8CI) with a stability temperature of 120°C is used in heated batch processing, where sustained efficacy is maintained under elevated temperatures. Particle size <50 µm: Pyridine, 2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-, monohydrochloride (8CI) with a particle size less than 50 µm is used in tablet formulation, where fine particle distribution ensures uniformity and efficient compression. Solubility in water 100 mg/mL: Pyridine, 2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-, monohydrochloride (8CI) with solubility in water at 100 mg/mL is used in injectable drug preparation, where high solubility guarantees complete dissolution for accurate dosing. Assay >99%: Pyridine, 2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-, monohydrochloride (8CI) at assay values greater than 99% is used in analytical reference standards, where analytical accuracy is ensured for quality control procedures. Residual solvent <0.1%: Pyridine, 2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-, monohydrochloride (8CI) containing residual solvent below 0.1% is used in GMP-grade active pharmaceutical ingredient development, where strict compliance reduces contamination risk. |
Competitive Pyridine, 2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-, monohydrochloride (8CI) prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Years of manufacturing in the fine chemical sector have grounded us in the importance of reliable synthetic intermediates and specialty reagents. Among the compounds steadily in demand across pharmaceutical and research settings stands Pyridine, 2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-, monohydrochloride, referenced here as the 8CI compound. Hands-on production offers insight into more than technical details—consistent execution and adaptability form the foundation of our work.
Manufacturing the 8CI compound involves the conventional formation of its pyridine core, where experience with aromatic substitution and amination steps guides the process. The signature component—the p-chlorobenzyl group linked through the dimethylaminoethyl amine—provides unique reactivity, making this molecule stand out during downstream synthesis or in final API processes. Addition of monohydrochloride salt secures stability and sharply defined purity, key for bench-scale reliability and repeat performance in larger manufacturing runs.
Model variations center on reaction optimization, not mere cosmetic adjustments. Run-to-run, small changes in solvent purity, temperature control, or workup methods directly affect batch quality. Over years of adjustment and scale, the tightest batch-to-batch reproducibility comes from training and repetition. No automated system matches the vigilance of hands-on teams—anyone who claims easy, push-button yields isn't doing the work at scale. Analytical testing enforces standards throughout, from TLC checks in the early steps to HPLC, NMR, and MS fingerprinting after full crystallization. Purity levels regularly exceed 98% by HPLC, but chasing that last fraction means repeated re-crystallization or column separation. As a manufacturer, we value clarity about which purities are practical for each purpose.
The primary use of Pyridine, 2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-, monohydrochloride rests in advanced intermediate synthesis and occasionally as a component in specialty drug discovery routes. Drilling into the specifics, the molecule's tertiary amine moiety brings nucleophilic activity and salt formation potential, often capitalized upon during stepwise pharmaceutical developments or in targeted analytical research. Molecular features, such as the chloro-substituted aromatic ring, confer reactivity and tuning options unmatched by simpler pyridine derivatives. That extra complexity isn't academic: project chemists utilize such handles for further modification, radiolabeling, or late-stage derivatization.
Our experience watching researchers struggle with generic, less functional pyridines explains the need for this precise design. Some might think any pyridine intermediate suffices, but try running hydrogenations or coupling steps with too-labile analogues. Failures multiply—lower yields, side-products, extra purification headaches. The 8CI variant, with its built-in stability and selective reactivity, makes those headaches less likely. The monohydrochloride salt also makes for improved handling: compared to free base alternatives, we see less atmospheric moisture absorption, better shelf-life, and far easier weighing and transferring in the lab.
From customer feedback, smooth solids and reliable solubility in both polar and moderately non-polar solvents reduce time spent troubleshooting. In some cases, we've seen teams move directly from milligram trials to scale-up, skipping whole rounds of purification usually necessary with less-refined samples. As manufacturers, these details aren't mere footnotes—they drive efficiency and research confidence.
It's tempting to treat all substituted pyridines as comparable, but daily practice proves the difference. We routinely field requests for simple 2-aminopyridines or N,N-dimethylaminoethyl hybrids, often asked for as supposedly suitable swaps. Tests rarely bear that out. Running the same coupling, alkylation, or functionalization steps with less carefully designed intermediates brings up solubility problems and unpredictable reactivity.
The p-chlorobenzyl and 2-(dimethylamino)ethyl features deliver a blend of steric and electronic effects that behave consistently in most downstream steps. Simpler analogues either react too quickly, risking overalkylation, or too sluggishly, leading to unreacted residue, which means longer purification runs and higher costs. The dimensionality introduced by those substituents isn't a sales gimmick—it's a shield against waste and laboratory inefficiency. Newcomers to scale-up might miss the value of small improvements until seeing how hours saved in isolation or purity checks translate into budget space and fewer frustrations mid-project.
Even comparing monohydrochloride to dihydrochloride or other salt forms reveals practical advantages. Monohydrochloride delivers ample aqueous solubility for most needs but resists deliquescence seen with other salt forms. Handling over hundreds of batches, we've logged fewer incidents of caking or weight-loss due to atmospheric pickup. This isn't subtle—less need for repurification or drying keeps project timelines tight and product waste minimal.
Producing such an advanced intermediate reliably means confronting technical hurdles the lab textbooks gloss over. At the core, controlling moisture and temperature at each synthesis step requires constant attention. Even a minor uptick in humidity, overlooked during a sensitive step, throws yields off or forces lengthy post-run drying. By building closed-loop controls and physical screen barriers between humidity sources and scale-up reactors, crews dramatically reduce batch inconsistencies.
Traditional purification techniques, like liquid-liquid extraction or basic precipitation, often leave fine impurities. We have replaced some with multi-stage crystallization or tuned pH salting to drive higher purity in a single pass. Repeat syntheses taught us that patience with process time—stretching a temperature ramp by an hour, or letting a solution chill for longer—pays off in fewer filtrate impurities, sharply higher yields, and product easier to store. In high throughput environments, patience cuts costs—despite pressure to speed up, it’s one lesson we revisit regularly.
Another source of difference comes from solvent choice. Navigating between classical chlorinated or aromatic solvents and green chemistry alternatives pushes us to constantly assess environmental and worker safety. Substituting safer solvents, when possible, lowers waste disposal costs and improves air quality, an issue that gets more pressing at higher production volumes. We note subtle shifts in solubility and reaction selectivity with each change, so each new run comes with careful monitoring, not just blind substitution.
Salt formation and isolation also separate experienced manufacturers from general suppliers. Getting cleaner monohydrochloride involves controlled acid loading, pH checks by hand or titration, and avoidance of over-acidification which can trigger unwanted side-products. Teams familiar with the pinprick feel of slightly acid-reactive product know the tactile benchmarks—grains and clumps deliver different signals than sticky masses, and those cues help tell a seasoned technician from an occasional operator.
Direct conversation with medicinal chemists and process engineers brings feedback no written spec sheet covers. Batches flagged for off-odor, unexpected coloration, or slightly sticky texture soon yield stories behind specific lab protocols or downstream instruments. We almost always track these problems to solvent residues, lingering minor byproducts, or rarely, interactions with plastic storage containers. Solving these issues takes hands-on adjustment and willingness to rerun purification, not just pointing to a certificate of analysis.
We develop protocols layering small-scale lab testing and pilot plant simulation. Before a kilo leaves the site, at least two technicians will have compared solid flow, moisture resistance, and simple dissolving steps. Surprises almost always trace back to overlooked details—small, irregular crystals or over-dried product present as handling problems in customer labs. Years ago, labs flagged issues with filtration or solubility: fixing these meant changing not the chemistry, but the drying and final granulation step. Since then, nitrogen blanketing and low-humidity packing improved user experience more than any cosmetic spec list.
Our crew learns with every production cycle. Achieving high-grade Pyridine, 2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-, monohydrochloride takes daily recalibration, respect for small signals, and a drive for transparency. Working chemists increasingly demand more than a technical grade; needs push for analytical data beyond standard NMR or MS—requests for trace impurity breakdowns, residual solvent profiles and physical flow evidence come up during every project launch.
We don’t claim every batch is flawless. Many chemists want instant shipment of hundreds of grams at research grade—a challenge if upstream materials show supply gaps, or a novel analytical issue appears at random. Honest communication with R&D partners keeps mutual trust intact. We warn if storms delay shipments, if an impurity profile can’t meet a narrow new spec, or if price rises ahead of budget. Many customers accept a few days' wait over unknown substitutions from low-trace third parties. Open records build loyalty in ways a few cents saved do not.
From our production floor, limitations include reagent sourcing—the rarer the aryl precursor, the more volatile cost becomes. As new environmental protocols tighten, solvent recycling and waste recovery cost more in labor and infrastructure, but these steps protect our staff and the wider community. We often weigh cheaper overseas sourcing against proven reliability and compliance; most research-focused buyers know that a few dollars saved can mean many more lost to failed syntheses or inconclusive results.
As demand rises for more selective, elaborate intermediates, the bar rises for every batch. Simple copying of older synthetic routes no longer assures consistent performance; we upgrade methods as new green chemistry solutions and process automation options arrive on the market. The future lies in short, direct routes that minimize hazardous intermediates and volatile residues—a lesson that comes not from theory, but direct experience managing technical and personnel safety.
Collaborating with research partners brings a steady stream of custom modification requests. The 8CI compound often serves as a platform for further molecular tinkering—radioisotope labeling, side-chain extension, or masking with protective groups. Our production design now includes space for one-off reactions, not just bulk scale-up. That’s how the real world innovates: not with one-size-fits-all offerings, but by putting experienced hands on specific needs.
As a manufacturer, we value stability and honesty over clever marketing. Our work ethic shows in the physical product—crisp white solids, reliable melting point, clean spectra. Researchers need to trust the compound in their flask matches what’s on the data sheet, and that support is available if a problem arises. Internal records stretch back over decades, cataloging each design tweak, each batch improvement, and every customer conversation that led to a new process.
Today’s market brings a proliferation of intermediates and custom building blocks advertised over global online platforms. Those offerings can mask gaps in production quality or delay problem-solving. What matters isn't the frequency of shipments but the visible, prompt correction when an issue arises. We open the factory doors to outside auditors, welcome customer visits, and share batch histories. That openness, not mystery or evasion, keeps research and industrial partners returning.
Working as a direct manufacturer of advanced pyridines, especially the 8CI variant, means every day brings the chance to refine, troubleshoot, and support innovation. From crude intermediate through purification and packaging, real-world experience—with its blend of setbacks and breakthroughs—keeps quality genuine. We engage with research chemists, QC managers, and end-users not just as suppliers, but as practicing chemists. Their feedback tells us, better than any paper trail, what truly sets a reliable intermediate apart from a crowded field of “equivalent” offerings. Each specification we meet, every issue we resolve, returns value many times over.
Pyridine, 2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-, monohydrochloride isn’t just another supply item. For us, it’s a continual project in applied chemistry—where closeness to materials, responsiveness to customer reality, and pride in getting every small detail right pay back in trust and measurable results.